![Willem W. van Weperen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Willem W. van Weperen
Plus aucun poste en cours
Profil
Willem W.
van Weperen formerly worked at to-BBB Holding BV, as Chief Executive Officer, to-BBB technologies BV, as Chief Executive Officer, Amicus Therapeutics, Inc., as Regional Vice President from 2015 to 2020, Prosensa Holding NV, as Chief Commercial Officer, Naarden Agro Products BV, as Principal, Glaxo, Inc., as Clinical Researcher, and Genzyme Europe BV, as General Manager.
Mr. van Weperen received his graduate degree from the University of Utrecht and Masters Business Admin degree from Nimbas Bradford School of Management.
Anciens postes connus de Willem W. van Weperen
| Sociétés | Poste | Fin |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2020 |
| PROSENSA HOLDING NV | Corporate Officer/Principal | - |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical & biotherapeutic products | Corporate Officer/Principal | - |
Naarden Agro Products BV
 Naarden Agro Products BV Food: Meat/Fish/DairyConsumer Non-Durables Specializes in the processing and sales of various caseins | Corporate Officer/Principal | - |
to-BBB Holding BV
 to-BBB Holding BV Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in providing central nervous system drug technology to the pharmaceutical and biotechnology industries | Directeur Général | - |
Formation de Willem W. van Weperen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
to-BBB Holding BV
to-BBB Holding BV Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in providing central nervous system drug technology to the pharmaceutical and biotechnology industries | Health Technology |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology Develops medicines for brain disease treatment | Health Technology |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
Naarden Agro Products BV
Naarden Agro Products BV Food: Meat/Fish/DairyConsumer Non-Durables Specializes in the processing and sales of various caseins | Consumer Non-Durables |
Glaxo, Inc. | |
Genzyme Europe BV
Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical & biotherapeutic products | Health Technology |
Nimbas Bradford School of Management
 Nimbas Bradford School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
